Capital Power declares dividends for its Common and Preference shares
Get Alerts CPX Hot Sheet
Join SI Premium – FREE
EDMONTON, Alberta, April 28, 2026 (GLOBE NEWSWIRE) -- The Board of Directors for Capital Power Corporation (“Capital Power”) (TSX: CPX) declared a dividend of $0.6910 per share on the outstanding common shares for the quarter ending June 30, 2026. The dividend is payable on July 31, 2026 to shareholders of record at the close of business on June 30, 2026.
The Board of Directors also declared the following dividends on its Cumulative Rate Reset Preference Shares:
| Shares | TSX Stock Symbol | Dividend Per Share | Record Date | Payment Date | |
| Series 1 | CPX.PR.A | $0.3098750 | June 17, 2026 | June 30, 2026 | |
| Series 3 | CPX.PR.C | $0.4287500 | June 17, 2026 | June 30, 2026 | |
| Series 5 | CPX.PR.E | $0.4144375 | June 17, 2026 | June 30, 2026 | |
The dividends for the common shares and preference shares are 100% eligible dividends as defined by the Income Tax Act. Under this legislation, individuals resident in Canada may be entitled to enhanced dividend tax credits that reduce the income tax otherwise payable on these dividends.
About Capital Power
Capital Power (TSX: CPX) is one of North America’s leading independent power producers, with approximately 12 GW of generation capacity across 35 facilities. Our portfolio includes natural gas, renewables and battery energy storage solutions. We deliver power generation at utility-scale through a flexible and resilient fleet built to meet growing electricity demand. Backed by deep expertise and an investment-grade credit rating, we provide safe, reliable power communities can depend on. We are Powering Change by Changing Power™.
For more information, please contact:
| Media Relations: Katherine Perron (780) 392-5335 [email protected] | Investor Relations: Noreen Farrell (403) 461-5236 [email protected] |
Source: Capital Power Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in P
- NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness
- Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share